What to expect from CAR T-cell therapy for acute lymphoblastic leukaemia

CAR T-cell therapy uses some of your own immune cells. They are collected from the blood and prepared in a specialised laboratory so they can recognise a target on leukaemia cells, then returned to you by infusion. Before the infusion, your team may give conditioning treatment to make room for the cells. The schedule includes examinations, blood tests and a period of close observation. Your clinicians will explain how long monitoring lasts and whether you need to remain near the treatment centre after leaving hospital.

Arrange a reliable adult support person and follow the centre's instructions about travel, medicines, temperature checks and contact numbers. Keep a record of fever, chills, dizziness, headache, confusion, sleepiness and changes in speech or movement. Drink and eat according to the plan, rest as needed and avoid driving or operating machinery until the treating team says it is safe. Carry the treatment centre's emergency information because side effects can begin after the infusion.

Contact the treatment centre immediately for a fever, shaking chills, faintness, breathing difficulty, severe headache, confusion, unusual sleepiness, trouble speaking, weakness or a seizure. These symptoms may indicate a serious immune or neurological reaction and need prompt assessment. Do not wait for a routine appointment or assume a symptom is an ordinary part of recovery.

Which stages will happen in hospital? Who should I call day and night? When can I return to school, work or driving? Which medicines should I pause, and what monitoring will I need after treatment?